These final results, together with a former report displaying that a small-molecule ACKR3 agonist CCX771 displays anxiolytic-like actions in mice,2 help the strategy of targeting ACKR3 as a novel approach to modulate the opioid program, which could open new therapeutic avenues for opioid-similar Ailments. A exploration research posted in https://carolynp358okf6.creacionblog.com/profile